DMI Selected as Finalist for $2.25 Million Nokia Sensing XCHALLENGE

Cambridge October 20th 2014 – DMI, a team comprised of biotechnology experts, engineers and computer scientists, under the lead of Dr. Eugene Chan, has been officially selected as a finalist team in the Nokia Sensing XCHALLENGE, a global competition to develop breakthrough medical sensing technologies that will ultimately enable faster diagnoses and easier personal health monitoring. Team DMI, headquartered in Cambridge Massachusetts, with a cross-disciplinary team, is one of 11 finalists from four countries competing for their share of the $2.25M prize purse.

The final phase of the Nokia Sensing XCHALLENGE includes an online voting campaign accounting for 10% of a team’s overall score, with the remainder evaluated by a judging panel comprised of digital health and medical industry experts. Videos of the finalist teams and their breakthrough technologies can be viewed and voted on beginning October 21st through October 30th at

DMI is entering its rHEALTH technology into the competition. The rHEALTH was developed over the past several years with support from a dozen grants and contracts from NASA and the National Institutes of Health. The technology is designed to provide hundreds of lab values off a single drop of blood, packaged in a small form factor, and has the capability to perform continuous measurement of vitals over mulitple days. In conjunction with NASA, the device has been tested in both lunar and zero gravity on board a parabolic aircraft. Team DMI was also recently announced as a finalist for the $10M Qualcomm Tricorder XPRIZE.

“The mission of the rHEALTH technology is to democratize biomedical diagnostics,” said Dr. Chan. “It is designed to address the spectrum of test classes seen in medicine and make these broadly accessible by anyone, anywhere. We are thrilled to advance as a finalist in the Nokia Sensing XCHALLENGE as this competition truly raises the bar for development of novel sensing technologies.”

Teams are competing for a $525,000 Grand Prize and up to five Distinguished Awards, each valued at $120,000. The winning teams must demonstrate the highest merit in the areas of accuracy and consistency, demonstration quality, technical innovation, human factors, market opportunity, originality, and user experience. The winning teams will be announced on November 10, 2014. This is the second of two consecutive, separate competitions in the Nokia Sensing XCHALLENGE.

For more information, visit:

For more information about team DMI, visit

About DMI
DMI (DNA Medicine Institute) is a biomedical leading-edge research organization. Its mission is to provide cutting-edge products that advance patient care, alleviate human suffering, and treat disease through innovation. It is able to do this by integrating disparate fields such as medicine, nanotechnology, genomics, biophysics, biochemistry, molecular biology, and advanced engineering. Its core beliefs are that successful, innovative commercial products can make a long-lasting impact on researchers, patients, and consumers. It currently does research on intuitive medical devices, smartly designed drugs, and powerful research instrumentation. Unique attention is given to research and technologies that can have a broad impact and be deployed in all parts of the world.

Founded in 1995, XPRIZE is the leading organization solving the world’s Grand Challenges by creating and managing large-scale, high-profile, incentivized prizes in five areas: Learning; Exploration; Energy & Environment; Global Development; and Life Sciences. Active prizes include the $30M Google Lunar XPRIZE, the $15M Global Learning XPRIZE, the $10M Qualcomm Tricorder XPRIZE, the $2.25M Nokia Sensing XCHALLENGE and the $2M Wendy Schmidt Ocean Health XPRIZE. For more information, visit

Find us and support our efforts


Comments are closed.